---
$id: https://graph.org.ai/products/commodity/51292912
$type: Product
source: UNSPSC
code: "51292912"
title: "Mianserin"
class: "51292900"
classTitle: "Antidepressant dibenzazepines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mianserin

**UNSPSC Code**: 51292912
**Class**: [Antidepressant dibenzazepines](Antidepressant dibenzazepines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin antagonist and antidepressant agent and adrenergic antagonist with the molecular formula C18H20N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 250PJI13LM, chemically known as 1,2,3,4,10,14b-hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine but generally known as mianserin, which bears US NIH Compound Identifier 4184. European Medicines Agency schedules Mianserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08939MIG. The term MIANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules mianserin in its Anatomical Therapeutic Chemical (ATC) Classification. MIANSERIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mianserin under HS 29335995 and SITC 51576. As of Q4 2014, MIANSERIN remains the US FDA Preferred Term for this commodity. Mianserin bears US NLM identifiers UMLS ID C0025912 and NCI Concept Code C87209. SMILES: N12C(CN(CC1)C)c1c(Cc3c2cccc3)cccc1.

